Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
David M. Maahs(Stanford Medicine), John W. Lum(Diabetes Australia), Eyal Dassau(Harvard University), Steven C. Griffen(Breakthrough T1D), Steven J. Russell(Boston University), Roman Hovorka(Wellcome/MRC Institute of Metabolic Science), Brian Levy(Johnson & Johnson (United States)), Moshe Philip(Tel Aviv University), Ahmad Haidar(McGill University), J. Hans DeVries(Amsterdam UMC Location University of Amsterdam), Éric Renard(Inserm), Stuart A. Weinzimer(Yale University), Jessica R. Castle(Oregon Health & Science University), David N. O’Neal(St Vincent's Hospital Melbourne), Bruce A. Buckingham(Stanford Medicine), Howard Zisser(University of California, Santa Barbara), Ali Çınar(Illinois Institute of Technology), Lutz Heinemann, Boris Kovatchev(University of Virginia), Francis J. Doyle(Brown University), Edward R. Damiano(Boston University), Timothy W. Jones(Princess Margaret Hospital for Children), Craig Kollman(Jaeb Center for Health Research), Revital Nimri(Schneider Children's Medical Center)
Cited by 215
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
A rapid DNA isolation procedure for small amounts of fresh leaf tissue
|Medical Entomology and Zoology|1987|2.4k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
Dynamic Flux Balance Analysis of Diauxic Growth in Escherichia coli
|Biophysical Journal|2002|962
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
|New England Journal of Medicine|2019|960